WO2004087016A1 - Longitudinally expanding medical device - Google Patents
Longitudinally expanding medical device Download PDFInfo
- Publication number
- WO2004087016A1 WO2004087016A1 PCT/US2004/009379 US2004009379W WO2004087016A1 WO 2004087016 A1 WO2004087016 A1 WO 2004087016A1 US 2004009379 W US2004009379 W US 2004009379W WO 2004087016 A1 WO2004087016 A1 WO 2004087016A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- hoops
- elongated segment
- patient
- polymer material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0009—Making of catheters or other medical or surgical tubes
- A61M25/0012—Making of catheters or other medical or surgical tubes with embedded structures, e.g. coils, braids, meshes, strands or radiopaque coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/047—Urethrae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M2025/0024—Expandable catheters or sheaths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/005—Catheters; Hollow probes characterised by structural features with embedded materials for reinforcement, e.g. wires, coils, braids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0102—Insertion or introduction using an inner stiffening member, e.g. stylet or push-rod
Definitions
- This invention generally relates to medical devices and maintaining a body passageway open.
- Stents have been employed, for example, in the urethra, the ureters, the biliary tract, the cervix, the rectum, the esophagus, and blood vessels of mammals to relieve the pathological effects of constrictions or obstructions occurring in these passageways.
- BPH benign prostatic hyperplasia
- the medical device of the present invention includes a series of hoops surrounded by a flexible material defining a lumen therethrough. Similar to the bellows of an accordion, the flexible material collapses between adjacent hoops, forming a series of hinged members. Generally, longitudinal expansion is provided by the hinged members disposed between the hoops, and in-growth of tissue is prevented by the flexible material that bridges or otherwise encapsulates the hoops.
- the flexible material also forms a plurality of ridges at the locations where the flexible material circumscribes the hoops. These ridges inhibit migration of the stent through the prostatic urethra by engaging the adjacent tissue as the swelling prostate exerts lateral pressure on the stent.
- a multi-winged malecot or other radially expanding retention structure can be attached to a bladder-end of the stent to inhibit the stent from migrating out of the bladder.
- the malecot includes two or more wings that are collapsible to allow for passage of the prostatic stent into and through the urethra of the patient and expandable once located in the bladder.
- the multi-winged malecot can be biased in an extended configuration, such that the multi-winged malecot will return to the extended configuration in the absence of external forces acting upon the malecot.
- the invention is directed to a medical device for use in a body of a patient including an elongated segment including a plurality of hoops defining a lumen therethrough.
- the medical device further includes a flexible polymer material bridging the plurality of hoops that allows the elongated segment to expand and contract.
- each of the plurality of hoops comprises a wire.
- at least one of the wires includes a biocompatible material that includes stainless steel, titanium, a nickel-titanium alloy, or a polymer.
- Each of the hoops is spaced apart from at least one other of the hoops, in another embodiment.
- the flexible polymer material is disposed between the plurality of hoops, allowing the spaces between the plurality of hoops to expand and contract to accommodate prostatic swelling when the device is within the prostatic urethra of the patient.
- the flexible polymer material may include a low durometer silicone.
- the flexible polymer is resilient.
- the medical device includes a retention structure to inhibit migration of the device.
- the retention structure extends from a first end of the elongated segment and may include a coiled shape, a J-curl, a barb, or a malecot.
- the coiled shape is selected from the group consisting of conical, spherical, helical, frusto-conical, and combinations thereof.
- the elongated segment includes a second retention structure to inhibit migration of the device. The second retention structure extends from a second end of the elongated segment that is opposite the first end.
- the second retention structure may include a coiled shape, a J-curl, a barb, or a malecot.
- the coiled shape is selected from the group consisting of conical, spherical, helical, frusto-conical, and combinations thereof.
- the invention in another aspect, relates to a stent for use in a prostatic urethra of a patient including an elongated segment including a first end, a second end, a plurality of hoops defining a lumen therethrough, and a flexible polymer material bridging the plurality of hoops to facilitate expansion of the elongated segment during prostatic swelling when the stent is within the prostatic urethra of the patient.
- the stent also includes a first malecot comprising a proximal end and a distal end. The proximal end of the first malecot can be disposed at the first end of the elongated segment and a curved tip can be disposed at the distal end of the first malecot.
- each of the plurality of hoops includes a wire.
- at least one of the wires includes a biocompatible material that includes stainless steel, titanium, a nickel-titanium alloy, or a polymer.
- each of the hoops is spaced apart from at least one other of the hoops.
- the flexible polymer material includes a low durometer silicone in one embodiment. In another embodiment, the flexible polymer material is resilient.
- the invention is directed to a method of placing a stent in a prostatic urethra of a patient.
- the method includes the steps of providing a stent and inserting the stent into the prostatic urethra of the patient.
- the stent includes an elongated segment, including a plurality of hoops defining a lumen therethrough, and a flexible polymer material bridging the plurality of hoops that allows spaces between the plurality of hoops to expand and contract to accommodate swelling of a prostate when the stent is within the prostatic urethra of the patient.
- the stent includes a retention structure to inhibit migration of the stent.
- the retention structure extends from a first end of the elongated segment.
- the inserting step includes positioning the retention structure into a bladder of the patient.
- FIG. 1 is a schematic view of the male urinary system
- FIG. 2 is a schematic side view of an embodiment of a longitudinally expanding stent in accordance with the invention in a compact configuration
- FIG. 3 shows a schematic side view of the stent of FIG. 2 in an expanded configuration
- FIG. 4 is a schematic transverse cross-sectional view of the stent of FIG. 3 taken at line 4-4;
- FIGS. 5 A and 5B are schematic side views of an alternative stent in accordance with the invention showing a retention structure in a collapsed configuration and an extended configuration, respectfully;
- FIG. 6 is a schematic longitudinal cross-sectional view of the stent of FIGS. 5 A and 5B with a stylet inserted therein;
- FIGS. 7 A and 7B are schematic side views of the stent of FIGS. 5 A and 5B placed within a prostatic urethra of a patient showing the transition from a longitudinally collapsed state to a longitudinally expanded state, respectively, in response to prostatic swelling. Description
- FIG. 1 illustrates a typical male urinary system 1.
- the system 1 includes a bladder 2, a urethra 3, a sphincter 4, a meatus 5, and a prostate 6.
- the prostate 6 is a male reproductive organ that surrounds a section of the urethra 3 generally known as the prostatic urethra 7. Due to the prostate's location, the male urinary system 1 may be constricted and thus obstructed when the patient's prostate 6 enlarges. Stents in accordance with the invention will maintain an open passageway through the prostatic urethra 7 and expand longitudinally to accommodate swelling of the prostate 6.
- FIG. 2 illustrates the general structure of one embodiment of the invention.
- FIG. 2 depicts a stent 100 including an elongated segment 110 with a plurality of individual hoops 102 disposed therein.
- the hoops 102 are oriented substantially perpendicular to the longitudinal axis 130 of the stent 100 (See also FIG. 6).
- Each of the plurality of hoops 102 may be made from an element that can be circularized, such as, for example, a stainless steel wire.
- a wire of any biocompatible material such as, for example, a polymer, titanium, or a nickel-titanium alloy may be used.
- polymers include nylon based biocompatible polymers, polytetrafluoroethylene, silicone, polyurethane, polyethylene, and thermoplastic elastomers.
- the wire used to form each of the hoops 102 may have one of a variety of cross- sectional shapes, such as, for example, circular, square, rectangular, triangular, or trapezoidal.
- the wire has a circular cross-sectional shape having a cross-sectional area defined by the wire's diameter.
- the diameter or thickness, or more generally the cross- sectional area or shape of the wire selected for the hoops 102 influences the radial strength of the stent 100.
- the diameter of the wire selected needs to be sufficiently large to assure that proper radial strength of the stent 100 is achieved to prevent against obstruction of the patient's prostatic urethra 7 resulting from the constriction created by the patient's enlarged prostate 6.
- the diameter of the wire used to form the plurality of hoops 102 is generally in the range of from about 0.1 mm to about 3 mm, which corresponds to a cross-sectional area in the range of about 7.9 x 10 '3 mm 2 to about 7.1 mm 2 .
- the wire's diameter is 1 mm, which corresponds to a cross-sectional area of about 0.8 mm 2 .
- the elongated segment 110 also includes a flexible polymer material 108 that bridges or connects the plurality of hoops 102 forming a lumen therethrough.
- the hoops 102 can be embedded within the flexible polymer material 108.
- the flexible polymer material 108 encapsulates or forms a sheath around the plurality of hoops 102 (See, e.g., FIG. 6).
- the flexible polymer material 108 is a non-porous membrane that inhibits ingrowth of body tissue around the plurality of hoops 102 and into the lumen 402, thereby preventing encrustation of the prostatic stent 100.
- the flexible polymer material 108 may be constructed of a biocompatible plastic such as, but not limited to, any polyester, nylon based biocompatible polymers, polytetrafluoroethylene, silicone, polyurethane, polyethylene, and thermoplastic elastomers.
- the flexible polymer material 108 may be made from silicone having a hardness in the general range of about 0 to 80 on the Shore A durometer scale. In a particular embodiment, the flexible polymer material 108 is made from silicone having a hardness of about 10 on the Shore A durometer scale.
- the shape of the flexible polymer material 108 allows the stent 100 to expand longitudinally in response to prostatic swelling.
- the flexible polymer material 108 is collapsed between adjacent hoops 102 forming a plurality of hinged members 107 disposed along the length of the elongated segment 110.
- the stent 100 also has a plurality of ridges 109 disposed between adjacent hinged members 107. Both the hinged members 107 and the ridges 109 encircle the lumen 402 substantially perpendicular to a longitudinal axis 130 of the elongated segment 110, thereby forming an expandable bellows-like structure.
- the hoops 102 are arranged such that each hoop 102 is seated within a ridge 109, thus securing the plurality of hoops 102 within the flexible polymer material 108.
- the plurality of hinged members 107 allow the stent 100 to expand along a longitudinal axis 130 of the elongated segment 110, as shown in FIG. 3.
- the flexible polymer material 108 is resilient, allowing the stent 100 to regain its original shape after being deformed.
- the elongated segment 110 may be manufactured by various methods.
- the flexible polymer material 108 is produced by dipping an open-ended preform having a lumen extending therethrough and a shape substantially equivalent to the shape of the elongated segment 110 into a molten bath of silicone or other biocompatible polymer.
- the formed flexible polymer material 108 may then be removed from within the lumen of the preform and manually loaded with the hoops 102 using, for example, tweezers.
- the hoops 102 are inserted into the lumen 402 of the flexible polymer material 108 such that each hoop 102 is seated within a ridge 109 (See FIG. 2).
- the prostatic stent 100 may be manufactured using a bellows-shaped deformable mandrel with a plurality of hoops 102 disposed around the ridges of the bellows.
- the mandrel is dipped into a molten bath of silicone to create the elongated segment 110 including the formed flexible polymer material 108 with hinged members 107 and ridges 109 and the 'plurality of hoops 102 seated therein.
- the flexible polymer material 108 is subsequently removed by deforming the mandrel and disengaging the elongated segment 110.
- the stent 100 may be manufactured using liquid injection molding techniques, wherein the hoops 102 are properly arranged in a closed mold having a lumen extending therethrough and a shape substantially equivalent to the shape of the elongated segment 110.
- a liquid silicone for example, is subsequently injected into the mold, thereby embedding the hoops into a flexible lumen in accordance with the invention.
- the diameter of the elongated segment 110 is between about 16 French to about 22 French, preferably about 18 French to about 21 French, depending on the size of the patient.
- the length of the stent 100 may vary to suit the individual needs of particular patients.
- the length of the stent 100 in the compact configuration may be between about 2.5 cm to about 8.3 cm depending on the size of the patient's prostatic urethra 7, which varies in length from about 1.5 cm to about 7.6 cm.
- a conventional measuring catheter can be employed to determine the length of the patient's prostatic urethra 7.
- the stent 100 may be tailored to the individual needs of particular patients.
- FIG. 3 is a schematic side view of the stent 100 of FIG. 2 illustrating the expanded configuration.
- the hinged members 107 assume an open configuration, thus increasing a distance 111 between adjacent hoops 102.
- the stent 100 assumes an expanded configuration, as represented in FIG. 3.
- the amount of longitudinal expansion is limited only by the construction of the flexible polymer material 108.
- the distance 111 is between about 3 mm to about 6 mm, preferably about 4 mm to about 5 mm, with the flexible polymer material 108 in a neutral configuration, i. e. , neither compacted nor expanded.
- the range of expansion for the distance 111 i.e., from the compacted configuration to the expanded configuration
- the degree of expansion can be adjusted by, for example, varying a distance 404 that the hinged member 107 extends into the lumen 402 (See FIG. 4).
- the distance 404 depends on the outside diameter of the stent 100 and the desired range of expansion and should be designed such that the inside diameter of the lumen 402 is about 2 mm to about 6 mm, preferably about 3 mm to about 5 mm. The actual dimensions may be varied to suit a particular application. Also, longitudinal expansion may be adjusted by varying the elasticity of the flexible polymer material 108.
- the plurality of hinged members 107 may be biased in a compact configuration, as represented in FIG. 2.
- FIG. 4 depicts a transverse cross-sectional view of the stent 100 taken at line 4-4 of FIG. 3.
- FIG. 4 is an enlarged view of stent 100 and depicts a hoop 102, the flexible polymer material 108, and the lumen 402.
- the flexible polymer material 108' visible on the interior of the stent 100 creates the hinged member 107.
- the distance 404 represents a measure of how far the hinged member 107 extends into the lumen 402.
- the cross-sectional configurations of the lumen 402 can be circular, elliptical, polygonal, wedge-shaped, or combinations thereof.
- the elongated segment 110 may include retention structures coupled to a proximal end 104 and/or a distal end 105 of the stent 100.
- retention structures such as, for example, a coiled shape, a J-curl, a barb, or a malecot may be coupled to the distal end 105 of the elongated segment 110.
- FIGS. 5-7 A detailed embodiment of a stent 500 including a retention structure is shown in FIGS. 5-7.
- FIGS. 5 A and 5B are schematic representations of an alternative embodiment of a stent 500 including a distal region 520 with a malecot 550 and a curved end 525.
- the stent 500 is similar in construction to the stent 100 depicted in FIGS. 2-4.
- a distal end 505 of an elongated segment 510 is coupled to a proximal end 503 of a multi-winged malecot 550, which prevents the proximal migration of the stent 500.
- the malecot 550 includes wings 511 and a distal end 515.
- a four-winged malecot 550 is depicted; however, other embodiments could have two or more wings 511 to prevent the proximal migration of the stent 500.
- the malecot 550 also includes an orifice 508, which is in fluid communication with a lumen 12. In operation, at least some urine enters the stent 500 through the orifice 508 and flows proximally down the prostatic urethra 7.
- the malecot 550 has at least two distinct configurations; an extended configuration and a collapsed configuration.
- FIG. 5 A shows the stent 500 with the wings 511 of the malecot 550 in a substantially collapsed configuration.
- the medical professional extends the distal end 515 of the malecot 550 along the longitudinal axis 530 of the elongated segment 510. This may be carried out using a pushing device or stylet 600 (see FIG. 6) while inserting the stent 500 into the body of a patient.
- the malecot 550 is in the collapsed configuration during insertion so as not to injure the patient's urethra 3.
- the wings 511 of the malecot 550 are in the extended configuration.
- the outside diameter 535 of the malecot 550 in the extended configuration is greater than the diameter of the prostatic urethra 7.
- the malecot 550 is biased in the extended configuration and, therefore, will return to this configuration in the absence of external compressive forces acting upon it. Once the malecot 550 is positioned in the bladder 2, the wings 511 assume the extended configuration, thus preventing proximal migration down the prostatic urethra 7.
- the distal region 520 of the stent 500 may include a curved end 525 to assist the medical professional when inserting the stent 500 through the curved sections of the patient's urethra 3 (See FIG. 1).
- a small amount of metal or other radiopaque material such as, for example, bismuth, may be embedded within a distal tip 527 of the curved end 525, thereby enabling the physician to confirm the proper placement of the stent 500 by radiographic techniques.
- the stent 500 can further include a proximal retention structure (not shown) disposed on the proximal end 504.
- Attachment of the distal region 520 to the elongated segment 510 may be carried out using biocompatible adhesives or bonding techniques. Bonding of the components may be performed by heat bonding. Heat bonding functions by partially melting the material, allowing the melted material to adhere to a contacting surface or other component, and allowing the material to cool and harden, thus forming a bond. Heat bonding methods include radio frequency bonding, induction heating, and conduction heating. The material of a first component may be selected to melt at a similar temperature as a second component so that both components are melted during the heat bonding process. Alternatively, either the first or second component may be constructed from a material with a lower melting temperature than the other component in order that only the component with the lower melting temperature may melt during the bonding process.
- the distal region 520 may be bonded by the use of a solvent, such as cyclohexanone and/or methylethylketone.
- a silicone adhesive may be used.
- the solvent acts by dissolving and swelling the material of the components. As the materials dissolve and swell, the components adhere to each other. The solvent is then removed allowing for the dissolved and swollen materials to harden and thus complete the bonding process.
- the distal region 520 and/or retention structures may be integrally formed with the elongated segment 510.
- the prostatic stent 500 may be inserted into the body of a patient using a pushing device or stylet 600.
- the stylet 600 Prior to inserting the stent 500 into the patient, the stylet 600 is loaded into the lumen 512 of the stent 500 through a proximal end 504 of the elongated segment 510. As shown in FIG. 6, the stylet 600 is passed through the lumen 512 until the distal end 602 of the stylet 600 contacts and pushes against the curved end 525, causing the malecot 550 to assume the collapsed configuration. Referring to FIGS.
- a medical professional inserts the curved tip 525 into the patient's meatus 5 and advances the stent 500 into the urethra 3 by applying force to the stylet 600.
- the medial professional monitors the location of the stent 500.
- the elongated segment 510 is positioned substantially within the prostatic urethra 7 of the patient and the distal region 520 is located in the bladder 2.
- the medical professional retracts the stylet 600 from the patient's urinary system.
- the malecot 550 assumes an extended configuration, thus preventing proximal migration of the stent 500.
- the hoop 502 closest to the malecot 550 is especially radiopaque, thus allowing the physician to properly position the distal region 520 within the bladder 2 prior to deploying the malecot 500.
- FIGS. 7A and 7B illustrate the stent 500 positioned within the prostatic urethra 7 of a patient with a normal prostate 6 and an enlarged prostate 6', respectively.
- FIG. 7A depicts the malecot 550 in the extended configuration, which prevents the distal region 520 of the stent 500 from migrating out of the bladder 2.
- the elongated segment 510 is positioned substantially within the prostatic urethra 7 and is shown in the compact configuration. In operation, the stent 500 receives at least some urine through the orifice 508 and into the lumen 512 of the elongated segment 510.
- FIG. 7B depicts the stent 500 within a prostatic urethra 7 surrounded by an enlarged prostate 6'.
- the elongated segment 510 is shown in an expanded configuration, illustrating how the elongated segment 510 accommodates anatomical changes due to prostatic swelling.
- the shape of the elongated segment 510 inhibits migration through the prostatic urethra 7 during prostatic swelling. Ridges 509 distributed along the elongated segment 510 engage adjacent tissue 705, especially during prostatic swelling.
- lateral pressure exerted by the enlarged prostate 6' causes adjacent tissue 705 to embrace the ridges 509, thus frictionally engaging the elongated segment 510 and inhibiting migration through the prostatic urethra 7.
- hoops 502 provide support to prevent the prostatic urethra 7 from collapsing, thus maintaining the flow of urine out of the bladder 2 and into the urethra 3.
- the longitudinal expandability of the elongated segment 510 accommodates the anatomical changes associated with prostatic swelling and prevents occlusion of the stent 500.
- the frictionally engaged tissue 705 spreads apart the ridges 509 causing hinged members 507 to assume an open configuration.
- the elongated segment 510 expands commensurately with the adjacent prostatic tissue 6'.
- the elongated segment 510 is ready to re-extend in the event that prostatic swelling reoccurs.
- longitudinal expansion is particularly useful for minimizing patient discomfort due to compressive forces exerted on tissues lodged between the retention structure and the swelling prostate 6', such as, for example, the bladder wall 702. Discomfort is reduced by allowing the elongated segment 510 to expand commensurately with the swelling prostate 6' thus relieving the pressure exerted on the compressed tissues.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04758435A EP1605869A1 (en) | 2003-03-26 | 2004-03-26 | Longitudinally expanding medical device |
CA002519492A CA2519492A1 (en) | 2003-03-26 | 2004-03-26 | Longitudinally expanding medical device |
AU2004226434A AU2004226434B2 (en) | 2003-03-26 | 2004-03-26 | Longitudinally expanding medical device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/400,200 US6929663B2 (en) | 2003-03-26 | 2003-03-26 | Longitudinally expanding medical device |
US10/400,200 | 2003-03-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004087016A1 true WO2004087016A1 (en) | 2004-10-14 |
Family
ID=32989170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/009379 WO2004087016A1 (en) | 2003-03-26 | 2004-03-26 | Longitudinally expanding medical device |
Country Status (5)
Country | Link |
---|---|
US (2) | US6929663B2 (en) |
EP (1) | EP1605869A1 (en) |
AU (1) | AU2004226434B2 (en) |
CA (1) | CA2519492A1 (en) |
WO (1) | WO2004087016A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8241344B2 (en) | 2007-04-09 | 2012-08-14 | Tyco Healthcare Group Lp | Stretchable stent and delivery system |
CZ303676B6 (en) * | 2010-12-16 | 2013-02-27 | Lasák@Stanislav | Prostatic implant assembly |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050021123A1 (en) | 2001-04-30 | 2005-01-27 | Jurgen Dorn | Variable speed self-expanding stent delivery system and luer locking connector |
EP1455688B1 (en) * | 2001-12-14 | 2010-09-15 | Aesculap AG | Vessel prosthesis, particularly for the replacement of aorta segments near the heart |
US8758372B2 (en) | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
US7297150B2 (en) * | 2002-08-29 | 2007-11-20 | Mitralsolutions, Inc. | Implantable devices for controlling the internal circumference of an anatomic orifice or lumen |
US7347866B2 (en) * | 2003-03-10 | 2008-03-25 | Boston Scientific Scimed, Inc. | Medical stent and related methods |
FR2852507B1 (en) * | 2003-03-17 | 2006-02-17 | VASCULAR PROSTHESIS | |
US6929663B2 (en) * | 2003-03-26 | 2005-08-16 | Boston Scientific Scimed, Inc. | Longitudinally expanding medical device |
DE102004018128A1 (en) * | 2004-04-08 | 2005-11-03 | Olympus Winter & Ibe Gmbh | Endoscope with different heights |
US20050240278A1 (en) * | 2004-04-26 | 2005-10-27 | Peter Aliski | Stent improvements |
US20050240141A1 (en) * | 2004-04-26 | 2005-10-27 | Peter Aliski | Stent kidney curl improvements |
US7470247B2 (en) * | 2004-04-26 | 2008-12-30 | Gyrus Acmi, Inc. | Ureteral stent |
US7507218B2 (en) * | 2004-04-26 | 2009-03-24 | Gyrus Acmi, Inc. | Stent with flexible elements |
SE0401708D0 (en) * | 2004-06-30 | 2004-06-30 | Wallsten Medical Sa | Balloon Catheter |
US8864823B2 (en) | 2005-03-25 | 2014-10-21 | StJude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
EP1861045B1 (en) | 2005-03-25 | 2015-03-04 | St. Jude Medical, Cardiology Division, Inc. | Apparatus for controlling the internal circumference of an anatomic orifice or lumen |
DE102005016103B4 (en) * | 2005-04-08 | 2014-10-09 | Merit Medical Systems, Inc. | Duodenumstent |
DE102005019649A1 (en) * | 2005-04-26 | 2006-11-02 | Alveolus Inc. | Flexible stent for positioning in lumen of esophagus comprises tube and stabilization members defined circumferentially about tube, where each member extends inwardly in tube to define inner diameter that is less than inner diameter of tube |
ATE526911T1 (en) | 2005-08-17 | 2011-10-15 | Bard Inc C R | VARIABLE SPEED STENT DELIVERY SYSTEM |
CA2936205C (en) * | 2006-01-13 | 2018-08-21 | C.R. Bard, Inc. | Stent delivery system |
US11026822B2 (en) | 2006-01-13 | 2021-06-08 | C. R. Bard, Inc. | Stent delivery system |
US7678141B2 (en) * | 2006-04-18 | 2010-03-16 | Medtronic Vascular, Inc. | Stent graft having a flexible, articulable, and axially compressible branch graft |
JP2009538166A (en) * | 2006-05-22 | 2009-11-05 | ドゥヴォネク マリアン | Prostate stent |
GB0615658D0 (en) | 2006-08-07 | 2006-09-13 | Angiomed Ag | Hand-held actuator device |
US9468746B2 (en) * | 2006-08-22 | 2016-10-18 | Medtronic Vascular, Inc. | Systems and methods for local bioactive material delivery |
US8029556B2 (en) | 2006-10-04 | 2011-10-04 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
MX2009007289A (en) | 2007-01-03 | 2009-09-09 | Mitralsolutions Inc | Implantable devices for controlling the size and shape of an anatomical structure or lumen. |
US8388679B2 (en) | 2007-01-19 | 2013-03-05 | Maquet Cardiovascular Llc | Single continuous piece prosthetic tubular aortic conduit and method for manufacturing the same |
JP5342548B2 (en) * | 2007-05-16 | 2013-11-13 | ドゥヴォネク マリアン | Stent positioning device |
US8617448B2 (en) * | 2007-05-17 | 2013-12-31 | Cook Medical Technologies Llc | Methods of making an endovascular prosthesis using a deformable matrix |
GB0713497D0 (en) | 2007-07-11 | 2007-08-22 | Angiomed Ag | Device for catheter sheath retraction |
US8142490B2 (en) * | 2007-10-24 | 2012-03-27 | Cordis Corporation | Stent segments axially connected by thin film |
MX2010005144A (en) | 2007-11-08 | 2010-08-02 | Renew Medical Inc | Fecal incontinence device, system and method. |
US10070955B2 (en) * | 2007-11-15 | 2018-09-11 | Boston Scientific Scimed, Inc. | Prosthesis with bendable central region |
US8287602B2 (en) * | 2007-12-12 | 2012-10-16 | Boston Scientific Scimed, Inc. | Urinary stent |
US8211004B1 (en) * | 2008-06-11 | 2012-07-03 | Bandula Wijay | Adjustable device for the treatment of female urinary incontinence |
US20100069784A1 (en) * | 2008-09-16 | 2010-03-18 | Blaivas Jerry G | Urological medical device and method for analyzing urethral properties |
US20100100170A1 (en) | 2008-10-22 | 2010-04-22 | Boston Scientific Scimed, Inc. | Shape memory tubular stent with grooves |
EP2389121B1 (en) | 2009-01-22 | 2020-10-07 | St. Jude Medical, Cardiology Division, Inc. | Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring |
US8603185B2 (en) * | 2010-03-11 | 2013-12-10 | Cook Medical Technologies Llc | Stent geometry |
GB201017834D0 (en) | 2010-10-21 | 2010-12-01 | Angiomed Ag | System to deliver a bodily implant |
US8696741B2 (en) | 2010-12-23 | 2014-04-15 | Maquet Cardiovascular Llc | Woven prosthesis and method for manufacturing the same |
US9572953B2 (en) * | 2010-12-30 | 2017-02-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Device having an electroformed pleated region and method of its manufacture |
WO2014018386A1 (en) | 2012-07-23 | 2014-01-30 | University Of Utah Research Foundation | Indwelling urinary catheter |
FR2995523A1 (en) | 2012-09-18 | 2014-03-21 | Ct Hospitalier Universitaire Rouen | ENDO-URETHRAL PROSTHESIS |
US10569052B2 (en) * | 2014-05-15 | 2020-02-25 | Auris Health, Inc. | Anti-buckling mechanisms for catheters |
RU2017130521A (en) * | 2015-01-30 | 2019-02-28 | Фьючерматрикс Интернэшнл | URINARY STENT |
US9808282B2 (en) * | 2015-06-04 | 2017-11-07 | Medos International Sarl | Surgical cannula system and method of use |
US10252025B2 (en) * | 2015-10-05 | 2019-04-09 | Justin Garcia | Urinary prostheses |
JP6887958B2 (en) * | 2016-01-15 | 2021-06-16 | テルモ株式会社 | How to use percutaneous catheter and percutaneous catheter |
CN110267627B (en) | 2016-12-09 | 2023-07-11 | 真复灵公司 | Systems, devices, and methods for accurately deploying implants in the prostatic urethra |
JP2023502997A (en) | 2019-11-19 | 2023-01-26 | ゼンフロー, インコーポレイテッド | Systems, devices and methods for accurate deployment and imaging of implants within the prostatic urethra |
US11273025B2 (en) | 2019-11-22 | 2022-03-15 | Pro Verum Limited | Expandable implant delivery device |
US11602621B2 (en) | 2019-11-22 | 2023-03-14 | ProVerum Limited | Device for controllably deploying expandable implants |
GB2602834B (en) * | 2021-01-18 | 2023-04-26 | Grey Matter Designs Ltd | Improvements in or relating to fluid management systems |
CN112754727A (en) * | 2021-04-07 | 2021-05-07 | 德宝恒生科技服务有限公司 | Urethra implant and urethra implant assembly |
CN112754728B (en) * | 2021-04-07 | 2021-06-29 | 德宝恒生科技服务有限公司 | Artificial urethra and artificial urethra implantation kit |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0789602A1 (en) * | 1994-10-03 | 1997-08-20 | Menlo Care Inc. | Polymeric medical device systems having shape memory |
US5843166A (en) * | 1997-01-17 | 1998-12-01 | Meadox Medicals, Inc. | Composite graft-stent having pockets for accomodating movement |
EP0943299A1 (en) * | 1998-03-19 | 1999-09-22 | Indigo Medical, Incorporated | Intraluminal bellows medical construct and apparatus for using same |
US6039755A (en) * | 1997-02-05 | 2000-03-21 | Impra, Inc., A Division Of C.R. Bard, Inc. | Radially expandable tubular polytetrafluoroethylene grafts and method of making same |
US20020177902A1 (en) * | 2001-05-22 | 2002-11-28 | Rioux Robert F. | Draining bodily fluids with a stent |
US20030040803A1 (en) * | 2001-08-23 | 2003-02-27 | Rioux Robert F. | Maintaining an open passageway through a body lumen |
Family Cites Families (133)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3076737A (en) * | 1957-11-15 | 1963-02-05 | Fred T Roberts & Company | Corrugated annularly reinforced hose and method for its manufacture |
US3588920A (en) * | 1969-09-05 | 1971-06-29 | Sigmund A Wesolowski | Surgical vascular prostheses formed of polyester fiber paper |
GB1599997A (en) | 1977-01-24 | 1981-10-14 | Raychem Ltd | Coil connector |
US4130904A (en) * | 1977-06-06 | 1978-12-26 | Thermo Electron Corporation | Prosthetic blood conduit |
US4164045A (en) * | 1977-08-03 | 1979-08-14 | Carbomedics, Inc. | Artificial vascular and patch grafts |
US4222384A (en) | 1977-11-09 | 1980-09-16 | Biomedical Engineering Associates, Inc. | Catheter |
US4307723A (en) | 1978-04-07 | 1981-12-29 | Medical Engineering Corporation | Externally grooved ureteral stent |
US4350161A (en) * | 1980-05-09 | 1982-09-21 | Davis Jr Richard C | Indwelling urethral catheter and method |
US4432757A (en) | 1980-05-09 | 1984-02-21 | Davis Jr Richard C | Indwelling urethral catheter |
US4501580A (en) | 1980-12-12 | 1985-02-26 | Glassman Jacob A | Indwelling catheters |
SE446713B (en) | 1981-02-10 | 1986-10-06 | Verkstadsservice Ab | INU DRIVE CONTROL DEVICE |
CA1186192A (en) | 1982-01-27 | 1985-04-30 | David S. Hickey | Urethral catheter |
US4911716A (en) | 1982-04-30 | 1990-03-27 | Hansa Medical Products, Inc. | Surgical implant for a voice prosthesis |
SE445884B (en) | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4531933A (en) * | 1982-12-07 | 1985-07-30 | C. R. Bard, Inc. | Helical ureteral stent |
US4512338A (en) | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US5104399A (en) * | 1986-12-10 | 1992-04-14 | Endovascular Technologies, Inc. | Artificial graft and implantation method |
JPS60187737U (en) * | 1984-05-23 | 1985-12-12 | オリンパス光学工業株式会社 | Indwelling tube guide device |
ES8705239A1 (en) | 1984-12-05 | 1987-05-01 | Medinvent Sa | A device for implantation and a method of implantation in a vessel using such device. |
US4798606A (en) | 1985-02-26 | 1989-01-17 | Corvita Corporation | Reinforcing structure for cardiovascular graft |
US4699611A (en) * | 1985-04-19 | 1987-10-13 | C. R. Bard, Inc. | Biliary stent introducer |
US4660560A (en) | 1985-05-30 | 1987-04-28 | The Beth Israel Hospital Association | Method for treating obstructive prostatism |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
IL78756A0 (en) | 1986-05-12 | 1986-08-31 | Biodan Medical Systems Ltd | Catheter and probe |
US4713049A (en) | 1986-08-05 | 1987-12-15 | Medical Engineering Corporation | Ureteral stent kit |
US5312430A (en) | 1986-12-09 | 1994-05-17 | Rosenbluth Robert F | Balloon dilation catheter |
US5030227A (en) | 1988-06-02 | 1991-07-09 | Advanced Surgical Intervention, Inc. | Balloon dilation catheter |
US4893623A (en) | 1986-12-09 | 1990-01-16 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US4907336A (en) | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4813925A (en) | 1987-04-21 | 1989-03-21 | Medical Engineering Corporation | Spiral ureteral stent |
US5527337A (en) | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
US4795458A (en) | 1987-07-02 | 1989-01-03 | Regan Barrie F | Stent for use following balloon angioplasty |
US4813935A (en) | 1987-07-27 | 1989-03-21 | Habley Medical Technology Corporation | Urinary catheter |
US4861337A (en) | 1988-03-02 | 1989-08-29 | Sherwood Medical Company | Collapsible urethral catheter |
US4889137A (en) | 1988-05-05 | 1989-12-26 | The United States Of America As Reprsented By The Department Of Health And Human Services | Method for improved use of heart/lung machine |
US5220927A (en) | 1988-07-28 | 1993-06-22 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
US5226913A (en) | 1988-09-01 | 1993-07-13 | Corvita Corporation | Method of making a radially expandable prosthesis |
US5019090A (en) | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5092877A (en) | 1988-09-01 | 1992-03-03 | Corvita Corporation | Radially expandable endoprosthesis |
US5085629A (en) | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
US4994066A (en) | 1988-10-07 | 1991-02-19 | Voss Gene A | Prostatic stent |
US4995868A (en) | 1988-10-12 | 1991-02-26 | Bard Limited | Catheter |
US4931037A (en) | 1988-10-13 | 1990-06-05 | International Medical, Inc. | In-dwelling ureteral stent and injection stent assembly, and method of using same |
US4985022A (en) | 1988-11-23 | 1991-01-15 | Med Institute, Inc. | Catheter having durable and flexible segments |
US5116309A (en) | 1989-01-25 | 1992-05-26 | Coll Milton E | Ureteral stent-catheter system having varying diameter stent |
US4990155A (en) | 1989-05-19 | 1991-02-05 | Wilkoff Howard M | Surgical stent method and apparatus |
US5059169A (en) | 1989-07-07 | 1991-10-22 | C. R. Bard, Inc. | High-friction prostatic stent |
US4955859A (en) | 1989-07-07 | 1990-09-11 | C. R. Bard, Inc. | High-friction prostatic stent |
US4973301A (en) | 1989-07-11 | 1990-11-27 | Israel Nissenkorn | Catheter and method of using same |
DE9010130U1 (en) | 1989-07-13 | 1990-09-13 | American Medical Systems, Inc., Minnetonka, Minn., Us | |
US5002558A (en) | 1989-08-23 | 1991-03-26 | The Beth Israel Hospital Association | Adjustable urethral catheter and method for treating obstructive prostatism |
US5041092A (en) | 1989-08-29 | 1991-08-20 | Medical Engineering Corporation | Urethral indwelling catheter with magnetically controlled drainage valve and method |
US5007868A (en) | 1990-01-22 | 1991-04-16 | Trenton Fry | Replaceable skeg for a marine propulsion device |
FR2660543B1 (en) | 1990-04-06 | 1998-02-13 | Technomed Int Sa | METHOD FOR AUTOMATICALLY MEASURING THE VOLUME OF A TUMOR, IN PARTICULAR A PROSTATE TUMOR, MEASURING DEVICE, METHOD AND APPARATUS COMPRISING THE SAME. |
US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
US5221261A (en) | 1990-04-12 | 1993-06-22 | Schneider (Usa) Inc. | Radially expandable fixation member |
IL94138A (en) | 1990-04-19 | 1997-03-18 | Instent Inc | Device for the treatment of constricted fluid conducting ducts |
US5078720A (en) | 1990-05-02 | 1992-01-07 | American Medical Systems, Inc. | Stent placement instrument and method |
US5078736A (en) | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5139515A (en) * | 1990-08-15 | 1992-08-18 | Francis Robicsek | Ascending aortic prosthesis |
US5122154A (en) * | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5306241A (en) | 1990-08-16 | 1994-04-26 | Samples Charles R | Method of catheterization on and bladder drainage |
US5176625A (en) | 1990-10-25 | 1993-01-05 | Brisson A Glen | Stent for ureter |
US5356423A (en) | 1991-01-04 | 1994-10-18 | American Medical Systems, Inc. | Resectable self-expanding stent |
US5147370A (en) | 1991-06-12 | 1992-09-15 | Mcnamara Thomas O | Nitinol stent for hollow body conduits |
US5183033A (en) * | 1991-07-15 | 1993-02-02 | Wilk Peter J | Surgical instrument assembly and apparatus and surgical method |
US5222949A (en) | 1991-07-23 | 1993-06-29 | Intermed, Inc. | Flexible, noncollapsible catheter tube with hard and soft regions |
US5269802A (en) | 1991-09-10 | 1993-12-14 | Garber Bruce B | Prostatic stent |
US5183085A (en) | 1991-09-27 | 1993-02-02 | Hans Timmermans | Method and apparatus for compressing a stent prior to insertion |
US5500013A (en) | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US5234457A (en) | 1991-10-09 | 1993-08-10 | Boston Scientific Corporation | Impregnated stent |
US5354309A (en) | 1991-10-11 | 1994-10-11 | Angiomed Ag | Apparatus for widening a stenosis in a body cavity |
US5282860A (en) | 1991-10-16 | 1994-02-01 | Olympus Optical Co., Ltd. | Stent tube for medical use |
US5167614A (en) | 1991-10-29 | 1992-12-01 | Medical Engineering Corporation | Prostatic stent |
US5372600A (en) | 1991-10-31 | 1994-12-13 | Instent Inc. | Stent delivery systems |
US5176626A (en) | 1992-01-15 | 1993-01-05 | Wilson-Cook Medical, Inc. | Indwelling stent |
US5226979A (en) | 1992-04-06 | 1993-07-13 | Johnson Service Company | Apparatus including a shape memory actuating element made from tubing and a means of heating |
US5224953A (en) | 1992-05-01 | 1993-07-06 | The Beth Israel Hospital Association | Method for treatment of obstructive portions of urinary passageways |
US5383927A (en) * | 1992-05-07 | 1995-01-24 | Intervascular Inc. | Non-thromogenic vascular prosthesis |
US5383928A (en) | 1992-06-10 | 1995-01-24 | Emory University | Stent sheath for local drug delivery |
DE4220295A1 (en) | 1992-06-20 | 1993-12-23 | Angiomed Ag | Device for correcting the position of a stent |
US5322501A (en) | 1992-10-02 | 1994-06-21 | Mahmud Durrani Ayaz | Continent urethral stent for treating and preventing urethral stricture after surgery |
DE9213656U1 (en) | 1992-10-09 | 1992-12-03 | Angiomed Ag, 7500 Karlsruhe, De | |
US5300022A (en) | 1992-11-12 | 1994-04-05 | Martin Klapper | Urinary catheter and bladder irrigation system |
US5599291A (en) | 1993-01-04 | 1997-02-04 | Menlo Care, Inc. | Softening expanding ureteral stent |
FR2701648B1 (en) * | 1993-02-19 | 1995-03-31 | Marian Devonec | Prosthesis intended for the treatment of a light or natural way, in particular endo-urethral prosthesis. |
SE505436C2 (en) | 1993-04-27 | 1997-08-25 | Ams Medinvent Sa | prostatic stent |
US5472435A (en) | 1993-05-21 | 1995-12-05 | Navarre Biomedical, Ltd. | Drainage catheter |
IL105828A (en) | 1993-05-28 | 1999-06-20 | Medinol Ltd | Medical stent |
US5391196A (en) | 1993-06-18 | 1995-02-21 | Devonec; Marian | Method for therapeutic treatment of an obstructed natural canal |
FR2706764B1 (en) | 1993-06-24 | 1995-08-04 | Synthelabo | |
US5476505A (en) | 1993-11-18 | 1995-12-19 | Advanced Cardiovascular Systems, Inc. | Coiled stent and delivery system |
US5352198A (en) | 1993-11-24 | 1994-10-04 | Uresil Corporation | Locking catheter system |
US5476506A (en) * | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
US5441516A (en) | 1994-03-03 | 1995-08-15 | Scimed Lifesystems Inc. | Temporary stent |
US5554181A (en) | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
CA2147547C (en) * | 1994-08-02 | 2006-12-19 | Peter J. Schmitt | Thinly woven flexible graft |
US5531741A (en) | 1994-08-18 | 1996-07-02 | Barbacci; Josephine A. | Illuminated stents |
US5601591A (en) | 1994-09-23 | 1997-02-11 | Vidamed, Inc. | Stent for use in prostatic urethra, apparatus and placement device for same and method |
US5514176A (en) | 1995-01-20 | 1996-05-07 | Vance Products Inc. | Pull apart coil stent |
US5833707A (en) | 1995-07-05 | 1998-11-10 | Advanced Cardiovascular Systems, Inc. | Removable stent and method of deployment |
US5776161A (en) | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
US6162244A (en) * | 1996-03-29 | 2000-12-19 | Willy Ruesch Ag | Layered stent |
US5830179A (en) | 1996-04-09 | 1998-11-03 | Endocare, Inc. | Urological stent therapy system and method |
US6416537B1 (en) * | 1996-12-03 | 2002-07-09 | Atrium Medical Corporation | Multi-stage prosthesis |
US5897587A (en) * | 1996-12-03 | 1999-04-27 | Atrium Medical Corporation | Multi-stage prosthesis |
US5795319A (en) | 1997-03-07 | 1998-08-18 | Circon Corporation | Easily removable ureteral stent |
US5916195A (en) | 1998-02-04 | 1999-06-29 | Argomed Ltd. | Internal catheter |
US6129756A (en) * | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
US6033413A (en) | 1998-04-20 | 2000-03-07 | Endocare, Inc. | Stent delivery system |
US6071307A (en) * | 1998-09-30 | 2000-06-06 | Baxter International Inc. | Endoluminal grafts having continuously curvilinear wireforms |
US6494879B2 (en) * | 1998-10-15 | 2002-12-17 | Scimed Life Systems, Inc. | Treating urinary retention |
US6258117B1 (en) * | 1999-04-15 | 2001-07-10 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6358275B1 (en) * | 1999-10-04 | 2002-03-19 | Sulzer Carbomedics Inc. | Tissue-derived vascular grafts and methods for making the same |
US6673042B1 (en) * | 1999-11-22 | 2004-01-06 | Wilfred J. Samson | Expandable venous cannula and method of use |
EP1274479B1 (en) | 2000-04-11 | 2010-07-14 | Boston Scientific Limited | Reinforced retention structures |
US6764519B2 (en) | 2000-05-26 | 2004-07-20 | Scimed Life Systems, Inc. | Ureteral stent |
WO2002017990A2 (en) * | 2000-08-31 | 2002-03-07 | Abbeymoor Medical, Inc. | Diagnostic urethral assembly & method |
WO2002058541A2 (en) * | 2001-01-23 | 2002-08-01 | Abbeymoor Medical, Inc. | Endourethral device & method |
ATE272369T1 (en) * | 2001-03-27 | 2004-08-15 | Cook William Europ | VESSEL TRANSPLANT FOR THE AORTA |
US20040215322A1 (en) * | 2001-07-06 | 2004-10-28 | Andrew Kerr | Stent/graft assembly |
US6494855B2 (en) | 2001-05-16 | 2002-12-17 | Scimed Life Systems, Inc. | Draining bodily fluid |
US6887215B2 (en) | 2001-06-01 | 2005-05-03 | Boston Scientific Scimed, Inc. | Compressible ureteral stent for comfort |
US6796999B2 (en) * | 2001-09-06 | 2004-09-28 | Medinol Ltd. | Self articulating stent |
CN100479786C (en) * | 2001-11-28 | 2009-04-22 | 阿普特斯内系统公司 | Endovascular aneurysm repair system |
US20030199961A1 (en) * | 2002-04-03 | 2003-10-23 | Bjorklund Vicki L. | Method and apparatus for fixating a pacing lead of an implantable medical device |
DE10219014A1 (en) * | 2002-04-27 | 2003-11-13 | Ruesch Willy Gmbh | Self-expanding stent for reinforcing and/or keeping open a hollow organ comprise two elastic tubular layers which bracket and positionally fix at least one helical filament |
US7081132B2 (en) * | 2002-05-16 | 2006-07-25 | Cook Incorporated | Flexible barb for anchoring a prosthesis |
DE10223399B4 (en) * | 2002-05-25 | 2006-06-14 | Haindl, Hans, Dr.med. | Vascular support (STENT) and method of making such a vascular support |
US20040019375A1 (en) * | 2002-07-26 | 2004-01-29 | Scimed Life Systems, Inc. | Sectional crimped graft |
US6929663B2 (en) * | 2003-03-26 | 2005-08-16 | Boston Scientific Scimed, Inc. | Longitudinally expanding medical device |
-
2003
- 2003-03-26 US US10/400,200 patent/US6929663B2/en not_active Expired - Lifetime
-
2004
- 2004-03-26 AU AU2004226434A patent/AU2004226434B2/en not_active Ceased
- 2004-03-26 WO PCT/US2004/009379 patent/WO2004087016A1/en active Application Filing
- 2004-03-26 EP EP04758435A patent/EP1605869A1/en not_active Withdrawn
- 2004-03-26 CA CA002519492A patent/CA2519492A1/en not_active Abandoned
-
2005
- 2005-06-22 US US11/159,591 patent/US7842098B2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0789602A1 (en) * | 1994-10-03 | 1997-08-20 | Menlo Care Inc. | Polymeric medical device systems having shape memory |
US5843166A (en) * | 1997-01-17 | 1998-12-01 | Meadox Medicals, Inc. | Composite graft-stent having pockets for accomodating movement |
US6039755A (en) * | 1997-02-05 | 2000-03-21 | Impra, Inc., A Division Of C.R. Bard, Inc. | Radially expandable tubular polytetrafluoroethylene grafts and method of making same |
EP0943299A1 (en) * | 1998-03-19 | 1999-09-22 | Indigo Medical, Incorporated | Intraluminal bellows medical construct and apparatus for using same |
US20020177902A1 (en) * | 2001-05-22 | 2002-11-28 | Rioux Robert F. | Draining bodily fluids with a stent |
US20030040803A1 (en) * | 2001-08-23 | 2003-02-27 | Rioux Robert F. | Maintaining an open passageway through a body lumen |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8241344B2 (en) | 2007-04-09 | 2012-08-14 | Tyco Healthcare Group Lp | Stretchable stent and delivery system |
US9962274B2 (en) | 2007-04-09 | 2018-05-08 | Covidien Lp | Stretchable stent and delivery |
US10687967B2 (en) | 2007-04-09 | 2020-06-23 | Covidien Lp | Stretchable stent and delivery system |
CZ303676B6 (en) * | 2010-12-16 | 2013-02-27 | Lasák@Stanislav | Prostatic implant assembly |
Also Published As
Publication number | Publication date |
---|---|
US7842098B2 (en) | 2010-11-30 |
AU2004226434B2 (en) | 2009-11-05 |
US6929663B2 (en) | 2005-08-16 |
US20040193283A1 (en) | 2004-09-30 |
US20050267566A1 (en) | 2005-12-01 |
EP1605869A1 (en) | 2005-12-21 |
AU2004226434A1 (en) | 2004-10-14 |
CA2519492A1 (en) | 2004-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6929663B2 (en) | Longitudinally expanding medical device | |
US8388691B2 (en) | Drainage devices | |
US7112226B2 (en) | Male urethral stent device | |
US7041139B2 (en) | Ureteral stents and related methods | |
EP1434536B1 (en) | Prostatic stent and delivery system | |
US7044981B2 (en) | Ureteral stent configured for improved patient comfort and aftercare | |
US20090149935A1 (en) | Expandable stent | |
US6676623B2 (en) | Drainage devices and methods | |
US6676624B2 (en) | Drainage devices and methods | |
JPH04501525A (en) | high friction prostate stent | |
US20100010478A1 (en) | Intraurethral catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004226434 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2519492 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004758435 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004226434 Country of ref document: AU Date of ref document: 20040326 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004226434 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004758435 Country of ref document: EP |